Xinhua Medical Instrument And Guowei Medical Instrument To Set Up Medical Device Firm
This article was originally published in PharmAsia News
Executive Summary
Shandong Xinhua Medical Instrument will collaborate with Shandong Guowei Medical Instrument Investment to set up Guangzhou Taimei Medical Devices. Shandong Xinhua will invest RMB 4 million and Shandong Guowei will invest RMB 16 million in the joint venture. The new firm, which will act as an agent for Johnson & Johnson's orthopedics medical devices, will focus on the operation of these devices. (Click here for more - Chinese Language)
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.